2 ms·
Carboplatin is still used very prevalently for many cancers. It is now off patent, and old, but sitll in very common use in developed and developing countries.
by michaelforrest 8y ago
Carboplatin is still used very prevalently for many cancers. It is now off patent, and old, but sitll in very common use in developed and developing countries. It is one of the most used cancer drugs.
I've led with patents rather than papers because the latter can prevent the former ("prior art"). And no company will take a drug through clinical trials without a patent(s), and it is typically only companies that fund trials (espcially Phase III). So, publishing without patenting, if you actually have something promising, is near on a crime. It effectively renders it forever lost. This isn't actually as well known as it should be amongst researchers. Although most will never get to any point that this is of concern anyhow.
RE: the crowdfunding page, thank you for your tips/advice on how to make it better, but today is the last day and as you can see....it is a bust. So, that is that.